Cat Allergy in Human Market is Driven by Biotech Progress and Pet Ownership by 2025-2033 | Kenvue Brands LLC., Bayer AG, Sanofi, Haleon Group of Companies., GSK Plc.

The Global Cat Allergy in Human Market reached US$ 0.73 billion in 2023 and is expected to reach US$ 1.19 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2024-2032.

The latest Cat Allergy in Human Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/cat-allergy-in-human-market?ophp

Cat allergy in humans is caused by an immune response to proteins found in cat saliva, skin, and dander, leading to symptoms like sneezing and asthma. The market for treatments, including monoclonal antibodies and allergen-reducing therapies, is growing with increasing pet ownership and allergy awareness.

Cat Allergy in Human Market Competitors Overview:

Kenvue Brands LLC., Bayer AG, Sanofi, Haleon Group of Companies., GSK Plc., Johnson & Johnson Services, Inc., Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Perrigo Company. among others.

Important Industry Updates of 2024 and 2025:

✅ In January 2024, ANGANY Inc., announced the positive results of phase 1 clinical trials for its novel biological drug ANG-101. Angany is the first company to initiate clinical trials for cat allergy in humans. The investigational candidate which is an immunotherapy drug showed a significant safety profile, with mild and reversible side effects among the subject population.

✅ In August 2024, the U.S. Food and Drug Administration (FDA) approved neffy (epinephrine nasal spray) for the treatment of type 1 allergic reactions including life-threatening anaphylaxis. Neffy demonstrated a significant improvement in blood pressure, and heart rate, similar to epinephrine injection. Although anaphylaxis is rare in cat allergy patients, this can be a life-saving treatment in the particular population group who experience it.

Cat Allergy in Human Market Segments Overview:

∎By Treatment Type (Antihistamines, Corticosteroids, Nasal Decongestants, Leukotriene Antagonists and Others)
∎By Route of Administration (Oral, Nasal, and Parenteral)
∎By Mode of Prescription (Over-the-Counter, and Prescription Based)
∎By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cat-allergy-in-human-market?ophp

Methodology and Scope:

This Cat Allergy in Human Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Cat Allergy in Human Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=cat-allergy-in-human-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Cat Allergy in Human market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Cat Allergy in Human market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.